Subscribe to the Magazine View this as website
FDA authorizes Moderna and Pfizer-BioNTech omicron-specific boosters

FDA authorizes Moderna and Pfizer-BioNTech omicron-specific boosters

The Food and Drug Administration has granted Moderna and Pfizer-BioNTech's bivalent COVID-19 booster vaccine emergency use authorization as the federal government prepares to roll out the updated shots to the public in the coming weeks.

Read the full story here.

YouTube

Get Byron York’s Daily Memo into your inbox.

Click here to sign up to start receiving it now.